HealthStream (NASDAQ:HSTM) Director Sells $105,615.39 in Stock

HealthStream, Inc. (NASDAQ:HSTM) Director Deborah Tate sold 3,281 shares of HealthStream stock in a transaction dated Thursday, November 5th. The stock was sold at an average price of $32.19, for a total value of $105,615.39. Following the transaction, the director directly owned 21,418 shares in the company, valued at $689,445.42. The trade was a 13.28% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

HealthStream Price Performance

HealthStream stock opened at $28.89 on Monday. The firm has a market cap of $844.17 million, a P/E ratio of 41.27, a P/E/G ratio of 3.01 and a beta of 0.45. The stock’s 50 day moving average is $31.20 and its 200 day moving average is $25.83. HealthStream, Inc. has a one year low of $19.50 and a one year high of $35.60.

HealthStream (NASDAQ:HSTM) last posted its quarterly earnings data on Monday, November 2nd. The technology company reported $0.18 EPS for the quarter, beating analysts’ consensus estimates of $0.16 by $0.02. HealthStream had a net margin of 6.25% and a return on equity of 6.37%. The company had revenue of $83.31 million for the quarter, compared to analyst estimates of $82.24 million. Equities analysts anticipate that HealthStream, Inc. will post 0.80 earnings per share for the current fiscal year.

HealthStream Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 27th. Stockholders of record on Monday, November 16th will be issued a dividend of $0.0350 per share. The ex-dividend date is Monday, November 16th. This represents a $0.14 annualized dividend and a dividend yield of 0.5%. HealthStream’s dividend payout ratio is currently 20.00%.

Trending Headlines about HealthStream

Here are the key news stories impacting HealthStream this week:

• Positive Sentiment: Buy rating upgrade: Zacks upgraded HSTM to Rank #2 (Buy), citing improving earnings prospects, which could support investor optimism. Zacks article
• Positive Sentiment: Raised guidance: HealthStream lifted its outlook, a potentially positive sign for expected business performance, although the article raises the question of whether prior gains already reflect the news. Yahoo Finance article
• Neutral Sentiment: Analyst views remain cautious: Canaccord Genuity raised its price target to $32 from $29 but maintained a Hold rating; Craig Hallum also moved its rating to Hold. These calls suggest limited conviction despite the higher target. Canaccord rating information Craig Hallum rating article
• Negative Sentiment: Multiple insider sales: On November 5, EVP Michael Manning Collier, CFO Scott Alexander Roberts, Director Deborah Tate and EVP Kevin O’Hara sold a combined 38,081 shares. Each reduced their individual holdings, a cluster of transactions that may weigh on sentiment, though insider sales alone do not establish a change in the company’s outlook. Collier SEC filing Roberts SEC filing Tate SEC filing O’Hara SEC filing

Institutional Trading of HealthStream

Large investors have recently added to or reduced their stakes in the stock. Arrowstreet Capital Limited Partnership grew its position in shares of HealthStream by 21.1% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 377,945 shares of the technology company’s stock valued at $7,827,000 after acquiring an additional 65,806 shares during the period. Quantinno Capital Management LP grew its holdings in HealthStream by 283.5% during the first quarter. Quantinno Capital Management LP now owns 50,169 shares of the technology company’s stock valued at $1,039,000 after purchasing an additional 37,088 shares during the period. Lazard Asset Management LLC grew its holdings in HealthStream by 268.2% during the first quarter. Lazard Asset Management LLC now owns 157,208 shares of the technology company’s stock valued at $3,256,000 after purchasing an additional 114,511 shares during the period. Bank of New York Mellon Corp purchased a new stake in HealthStream in the second quarter worth $6,199,000. Finally, Dimensional Fund Advisors LP increased its position in HealthStream by 6.4% in the first quarter. Dimensional Fund Advisors LP now owns 1,456,043 shares of the technology company’s stock worth $30,156,000 after buying an additional 87,177 shares during the last quarter. Hedge funds and other institutional investors own 69.58% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the company. Wall Street Zen lowered HealthStream from a “buy” rating to a “hold” rating in a report on Sunday. Weiss Ratings raised HealthStream from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, October 8th. Craig Hallum cut HealthStream from a “buy” rating to a “hold” rating and set a $40.00 price objective on the stock. in a research note on Tuesday, November 3rd. Canaccord Genuity Group upped their target price on shares of HealthStream from $29.00 to $32.00 and gave the stock a “hold” rating in a research note on Wednesday, November 4th. Finally, Citigroup restated a “market perform” rating on shares of HealthStream in a report on Tuesday, October 27th. One investment analyst has rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, HealthStream has an average rating of “Hold” and an average price target of $36.00.

HealthStream Company Profile

HealthStream, Inc provides workforce and provider solutions designed for healthcare organizations. Its software and services help hospitals, health systems, medical practices and other healthcare providers manage employee education, training, credentialing, compliance and professional development.

The company’s offerings include learning management and education tools, competency and performance-management solutions, and systems for managing provider credentials, privileging and enrollment.